Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical radical prostatectomy

By Coetzee L.J.   Hars V.   Paulson D.F.  

Urology, Vol. 47, Iss. 2, 1996-02 ,pp. : 232-235

Elsevier

Access to resources Recommend Favorite

Comparison of clinically nonpalpable prostate-specific antigen-detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomy

By Ghavamian R.   Blute M.L.   Bergstralh E.J.   Slezak J.   Zincke H.  

Urology, Vol. 54, Iss. 1, 1999-07 ,pp. : 105-110

Elsevier

Access to resources Recommend Favorite

Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy

By Khatami Ali   Hugosson Jonas   Wang Wanzhong   Damber Jan-Erik  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 1, 2009-02 ,pp. : 12-18

Informa Healthcare

Access to resources Recommend Favorite

Captopril may reduce biochemical (prostate-specific antigen) failure following radical prostatectomy for clinically localized prostate cancer

By Ronquist Gunnar   Frithz Goran   Wang Yu-Hui   Lindeborg Torsten  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 1, 2009-02 ,pp. : 32-36

Informa Healthcare

Access to resources Recommend Favorite

Management of patients with rising prostate-specific antigen after radical prostatectomy

By Laufer M.   Pound C.R.   Carducci M.A.   Eisenberger M.A.  

Urology, Vol. 55, Iss. 3, 2000-03 ,pp. : 309-315

Elsevier

Access to resources Recommend Favorite